Cooper Total Liabilities 2010-2024 | COO

Cooper total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Cooper total liabilities for the quarter ending July 31, 2024 were $4.183B, a 0.34% increase year-over-year.
  • Cooper total liabilities for 2023 were $4.108B, a 4.86% decline from 2022.
  • Cooper total liabilities for 2022 were $4.318B, a 62.06% increase from 2021.
  • Cooper total liabilities for 2021 were $2.664B, a 8.53% decline from 2020.
Cooper Annual Total Liabilities
(Millions of US $)
2023 $4,108
2022 $4,318
2021 $2,664
2020 $2,913
2019 $2,646
2018 $2,805
2017 $1,683
2016 $1,783
2015 $1,786
2014 $1,870
2013 $714
2012 $728
2011 $687
2010 $858
2009 $1,012
Cooper Quarterly Total Liabilities
(Millions of US $)
2024-07-31 $4,183
2024-04-30 $4,244
2024-01-31 $4,337
2023-10-31 $4,108
2023-07-31 $4,169
2023-04-30 $4,162
2023-01-31 $4,225
2022-10-31 $4,318
2022-07-31 $4,469
2022-04-30 $4,764
2022-01-31 $4,736
2021-10-31 $2,664
2021-07-31 $2,825
2021-04-30 $2,851
2021-01-31 $2,932
2020-10-31 $2,913
2020-07-31 $2,988
2020-04-30 $2,883
2020-01-31 $2,818
2019-10-31 $2,646
2019-07-31 $2,557
2019-04-30 $2,661
2019-01-31 $2,873
2018-10-31 $2,805
2018-07-31 $3,030
2018-04-30 $3,226
2018-01-31 $3,112
2017-10-31 $1,683
2017-07-31 $1,690
2017-04-30 $1,810
2017-01-31 $1,837
2016-10-31 $1,783
2016-07-31 $1,855
2016-04-30 $1,856
2016-01-31 $1,795
2015-10-31 $1,786
2015-07-31 $1,729
2015-04-30 $1,777
2015-01-31 $1,819
2014-10-31 $1,870
2014-07-31 $691
2014-04-30 $660
2014-01-31 $661
2013-10-31 $714
2013-07-31 $569
2013-04-30 $630
2013-01-31 $720
2012-10-31 $728
2012-07-31 $787
2012-04-30 $591
2012-01-31 $662
2011-10-31 $687
2011-07-31 $728
2011-04-30 $815
2011-01-31 $850
2010-10-31 $858
2010-07-31 $909
2010-04-30 $966
2010-01-31 $969
2009-10-31 $1,012
2009-07-31 $1,067
2009-04-30 $1,118
2009-01-31 $1,172
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.668B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95